Sublingual immunotherapy affects transforming growth factor-beta and nasal eosinophils.
Ciprandi
Giorgio
G
Tosca
Maria Angela
MA
D000286:Administration, Sublingual; D000328:Adult; D003888:Desensitization, Immunologic / Q000379:methods*; D004804:Eosinophils / Q000276:immunology*; D005260:Female; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D009297:Nasal Mucosa / Q000276:immunology*; D011058:Pollen / Q000276:immunology*; D006255:Rhinitis, Allergic, Seasonal / Q000276:immunology / Q000628:therapy*; D016212:Transforming Growth Factor beta / Q000097:blood*
D016212:Transforming Growth Factor beta